CSIMarket


Xtant Medical Holdings Inc   (XTNT)
Other Ticker:  
 


 

Xtant Medical Holdings Inc

XTNT's Financial Statements and Analysis



Xtant Medical Holdings Inc increased III. Quarter net loss per share of $-0.03 compare to net loss per share of $-0.02 recorded in the same quarter a year ago a decrease compare to $-0.02 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.03 $  14 Mill
$-0.01     $+1M     +4.97 %



Xtant Medical Holdings Inc 's Revenue rose by 4.97 % in III. Quarter (Sep 30 2022) year on year, to $14 million and declined by -5.33 % sequentially.


Xtant Medical Holdings Inc is Expected to report next financial results on March 07, 2023.

More on XTNT's Income Statement



Xtant Medical Holdings Inc 's in III. Quarter recorded net loss of $-2.353 million, an increase from net loss of $-1.804 million in III. Quarter a year ago.

Sequentially net loss advanced

More on XTNT's Growth

Inventories declined by -13.78 % to $16.99 million from III. Quarter a year ago, sequentially inventories rose by 3.23 %. XTNT's Cash flow In III. Quarter company's net cash flow was $1 million, capital expenditures fell by 24.63%, to $-1 millions compare to same quarter a year ago and fell by 56.75% from II. Quarter (Jun 30 2022).

More on XTNT's Cash flow Statement


Xtant Medical Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Xtant Medical Holdings Inc payed $ -0.03 cash per share, on a free-cash flow basis .